OVA1 is the best option for early detection.

Having risk factors doesn’t guarantee a diagnosis. It simply means you may have a greater chance of developing the disease. Learn more about how OVA1, Vermillion’s first-generation Multivariate Index Assay (MIA), is improving ovarian cancer detection.

Watch Video

Patient Education: Ovarian Cancer Testing

Resources

Your Personal Guide to Asking the Right Questions About Your Pelvic Mass

Discovering a pelvic mass can be scary and overwhelming experience. Download this guide to help settle those fears by better understanding what you’re facing and taking action with OVA1.

Download Guide

Benefits of OVA1

Historically, physicians have utilized the CA-125 as a blood test to evaluate the likelihood of ovarian cancer in patients. While there are no FDA-cleared ovarian cancer screening tests available, OVA1 (MIA) was developed to be better than CA-125 alone at detecting all types of ovarian cancer in patients with a pelvic mass scheduled for surgery. OVA1 (MIA) is highly sensitive meaning a low-risk patient should be managed by their obstetrician/ gynecologist or an elevated-risk patient should be referred to a gynecologic oncologist for surgical treatment. Your OVA1 (MIA) score determines if your mass is at lower risk for ovarian cancer or at a higher risk. Patients with elevated cancer risk may benefit from treatment by a gynecologic oncologist who specializes in the diagnosis and treatment of cancer in the reproductive organs. If cancer is present, getting to a specialist for the first surgery increases a woman’s chance of survival up to 40 percent.

Patients appropriate for referral to a gynecologic oncologist may benefit from:

  1. Effective surgery and treatment
  2. Timely medical management
  3. Improved survival rate and outcomes

Historically, physicians have utilized the CA-125 as a blood test to evaluate the likelihood of ovarian cancer in patients. OVA1 (MIA) was developed to be better than CA-125 alone at detecting all types of ovarian cancer. Ask your physician to order OVA1.

How to Receive OVA1 Testing

You Can Request OVA1

If you have a planned adnexal mass surgery, are experiencing ovarian cancer symptoms and you would like to have an OVA1 (MIA) test performed, please bring an ASPiRA LABS’ test request form with the patient portion completed to your healthcare provider. Your healthcare provider will help assess if OVA1 (MIA) is right for you and guide you through the next steps.

For Women

See What Others Are Saying About OVA1

OVA1 has been tested across the country by providers and women with positive outcomes.